Page last updated: 2024-09-05

fk 3311 and Ischemia

fk 3311 has been researched along with Ischemia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aiba, M; Iwazaki, S; Kasahara, M; Kawashima, Y; Kawate, S; Matsumoto, K; Morishita, Y; Ogawa, T; Ohwada, S; Sunose, Y; Takeyoshi, I; Tomizawa, N; Tsutsumi, H2
Iwazaki, S; Kawata, K; Matsumoto, K; Morishita, Y; Ohwada, S; Sunose, Y; Takeyoshi, I; Tokumine, M; Tomizawa, N; Tsutsumi, H1

Other Studies

3 other study(ies) available for fk 3311 and Ischemia

ArticleYear
The effect of cyclooxygenase 2 inhibitor (FK3311) on ischemia-reperfusion injury with hepatectomy in dogs.
    Transplantation proceedings, 2000, Volume: 32, Issue:7

    Topics: Anilides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspartate Aminotransferases; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dogs; Female; Hepatectomy; Ischemia; Isoenzymes; Liver; Liver Circulation; Male; Prostaglandin-Endoperoxide Synthases; Regional Blood Flow; Reperfusion Injury

2000
Effect of FK3311 on ischemia-reperfusion injury in canine pulmonary models.
    Transplantation proceedings, 2000, Volume: 32, Issue:7

    Topics: Anilides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiac Output; Dogs; Hemodynamics; Ischemia; Lung; Models, Animal; Oxygen; Partial Pressure; Pulmonary Artery; Pulmonary Circulation; Pulmonary Veins; Reference Values; Reperfusion Injury; Thromboxane B2; Vascular Resistance

2000
Effects of FK3311 on pulmonary ischemia-reperfusion injury in a canine model.
    The Journal of surgical research, 2001, Volume: 95, Issue:2

    Topics: 6-Ketoprostaglandin F1 alpha; Anilides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiac Output; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dogs; Epoprostenol; Hemodynamics; Ischemia; Isoenzymes; Lung; Neutrophils; Oxygen; Partial Pressure; Prostaglandin-Endoperoxide Synthases; Pulmonary Artery; Pulmonary Circulation; Pulmonary Veins; Reperfusion Injury; Thromboxane B2; Time Factors; Vascular Resistance

2001